WHO
WHO to review MSD’s Ebola vaccine for emergency use
December 24, 2015Manufacturing and Production, Research and Development Ebola vaccine, Ebola virus, MSD, WHO, Zebov
The World Health Organisation (WHO) has accepted MSD’s application for the company’s investigational Ebola vaccine, V920 (Zebov), to be reviewed …
Encouraging first results from trial of Merck’s Ebola vaccine
July 31, 2015Research and Development, Sales and Marketing Africa, EBV, Ebola, Ebola virus, Ebola virus disease, Vaccine, WHO, World Health Organisation, guinea, vaccination
The first trial of an experimental Ebola vaccine suggests it provides high protection against the disease as early as ten …
EMA backs GSK’s malaria vaccine for use in Africa
July 24, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CHMP, Committee for Medicinal Products for Human USE, EMA, European Medicines Agency, GSK, WHO, malaria, world health organization
GSK has taken a significant step forward toward being the first company to bring a malaria vaccine to market, after …
Novartis receives WHO nod for malaria drug Coartem
July 17, 2015Manufacturing and Production Coartem, Novartis, WHO, antimalarial, malaria, world health organization
The World Health Organization will add Novartis’ antimalarial treatment Coartem to the prequalified list of vaccines that is supplies to …
China flu vaccine gets WHO seal of approval
June 12, 2015Research and Development, Sales and Marketing Hualan Biological Bacterin, WHO, influenza
A Chinese influenza vaccine has been deemed safe and effective by The World Health Organization (WHO). The approval makes its …
World Health Organisation calls for full trial transparency
April 14, 2015Research and Development, Sales and Marketing Ben Goldacre, EU, WHO, World Health Organisation, alltrials, clinical trials, sense about science, transparency
The World Health Organization has thrown its weight behind clinical trial transparency in a new statement on its position. WHO …
WHO: New measures needed to reduce high drug costs
March 26, 2015Research and Development, Sales and Marketing Europe, WHO, pricing, transparency, world health organization
New approaches to drug pricing and reimbursement are needed to make sure pharma provides access to new medicines, according to …
Merck and NewLink Ebola vaccine trial begins
March 6, 2015Sales and Marketing Ebola, Merck, Vaccine, WHO, newlink, rVSV-EBOV
Merck and US-based biopharma firm NewLink Genetics’ investigational Ebola vaccine is being used in Phase III trials in West Africa. …
Flu vaccine ineffective against this season’s strain
February 6, 2015Research and Development, Sales and Marketing A(H3N2, Public Health England, UK, Vaccine, WHO, flu, phe
This season’s flu vaccine has provided little protection against the main strain circulating in the UK according to a new …
GSK launches Ebola Phase III trial in Liberia
January 23, 2015Research and Development, Sales and Marketing Africa, Ebola, GSK, US National Institutes of Health, WHO, Wellcome Trust, liberia, newlink
A shipment of GSK’s potential vaccine against the Ebola virus disease is on its way to Liberia ready to be …
Gilead and Strides partner in HIV
January 21, 2015Research and Development, Sales and Marketing Cipla, FDA, Gilead, HIV, Ranbaxy, Tenofovir Alafenamide, WHO, strides, taf
Gilead is partnering with India-based pharma firm Strides Arcolab in a licensing agreement to manufacture and distribute an HIV treatment …
UK nurse with Ebola in ‘critical condition’
January 6, 2015Research and Development, Sales and Marketing Africa, Ebola, GSK, Mapp, WHO, cafferky, johnson, zmapp
A British nurse that was diagnosed with Ebola last week is said to be in a critical condition at the …
GSK Ebola vaccine gets EU support
December 17, 2014Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson
A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …
Gavi pledges $300 million for Ebola vaccines
December 12, 2014Manufacturing and Production, Sales and Marketing GAVI, GSK, GlaxoSmithKline, J&J, JJ, Merck, Vaccine, WHO, newlink
The global vaccines alliance Gavi has committed to buying Ebola vaccines as soon as the World Health Organization recommends one …
Merck Ebola vaccine shows promise
December 4, 2014Research and Development, Sales and Marketing Ebola, Merck, VSV-ZEBOV, WHO, hug, newlink genetics
Merck and NewLink Genetics’ experimental Ebola vaccine has shown no major side effects in its first trial according to the …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
